Vanda presented preliminary data/findings from the first cohort of SMS patients who participated in their 2401 SMS clinical trial at the 2017 joint congress of World Association of Sleep Medicine and World Sleep Federation (World Sleep 2017) in Prague, Czech Republic, October 9-11, 2017. To view/download the abstract see Tasimelteon Improves Sleep Quality and Behavior in Individuals with Smith-Magenis Syndrome in an Open-Label Study.

In addition, Vanda is preparing to present this data in an online presentation to the SMS community in late October/early November. More information to come - stay tuned!